A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
Clinical trial NCT05592275 · TERMINATED
Trial details
- NCT number
- NCT05592275
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-03
- Primary completion
- 2025-01-22
- Enrollment
- 332
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.